FHNW Fachhochschule Nordwestschweiz
  • Startseite
  • Publikationen
  • Projekte
  • Studentische Arbeiten
  • de
  •  Login
Eintraganzeige 
  •   IRF Home
  • Hochschule für Life Sciences
  • Institut für Chemie und Bioanalytik
  • Eintraganzeige
  • Hochschule für Life Sciences
  • Institut für Chemie und Bioanalytik
  • Eintraganzeige
JavaScript is disabled for your browser. Some features of this site may not work without it.

Stem cell-derived systems in toxicology assessment

Datum
07.2015
Autorin/Autor
Suter-Dick, Laura
Alves, PM
Blaauboer, BJ
Bremm, KD
Brito, C
Coecke, S
Flick, B
Fowler, P
Hescheler, J
Ingelman-Sundberg, M
Jennings, P
Kelm, JM
Manou, I
Mistry, P
Moretto, A
Roth, A
Stedman, D
van de Water, B
Beilmann, M
Metadata
Zur Langanzeige
Type
01 - Zeitschriftenartikel, Journalartikel oder Magazin
Primary target group
Science
Created while belonging to FHNW?
Yes
Zusammenfassung
Industrial sectors perform toxicological assessments of their potential products to ensure human safety and to fulfill regulatory requirements. These assessments often involve animal testing, but ethical, cost, and time concerns, together with a ban on it in specific sectors, make appropriate in vitro systems indispensable in toxicology. In this study, we summarize the outcome of an EPAA (European Partnership of Alternatives to Animal Testing)-organized workshop on the use of stem cell-derived (SCD) systems in toxicology, with a focus on industrial applications. SCD systems, in particular, induced pluripotent stem cell-derived, provide physiological cell culture systems of easy access and amenable to a variety of assays. They also present the opportunity to apply the vast repository of existing nonclinical data for the understanding of in vitro to in vivo translation. SCD systems from several toxicologically relevant tissues exist; they generally recapitulate many aspects of physiology and respond to toxicological and pharmacological interventions. However, focused research is necessary to accelerate implementation of SCD systems in an industrial setting and subsequent use of such systems by regulatory authorities. Research is required into the phenotypic characterization of the systems, since methods and protocols for generating terminally differentiated SCD cells are still lacking. Organotypical 3D culture systems in bioreactors and microscale tissue engineering technologies should be fostered, as they promote and maintain differentiation and support coculture systems. They need further development and validation for their successful implementation in toxicity testing in industry. Analytical measures also need to be implemented to enable compound exposure and metabolism measurements for in vitro to in vivo extrapolation. The future of SCD toxicological tests will combine advanced cell culture technologies and biokinetic measurements to support regulatory and research applications. However, scientific and technical hurdles must be overcome before SCD in vitro methods undergo appropriate validation and become accepted in the regulatory arena.
URI
http://hdl.handle.net/11654/11971

Stöbern

Gesamter BestandBereiche & SammlungenErscheinungsdatumAutoren/AutorinnenTitelThemenDiese SammlungErscheinungsdatumAutoren/AutorinnenTitelThemen

Mein Benutzerkonto

EinloggenRegistrieren

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

Kontakt

Fachhochschule Nordwestschweiz FHNW
Vizepräsidium Hochschulentwicklung
Bahnhofstrasse 6
5210 Windisch

E-Mail: irf@fhnw.ch

Über das IRF

Das IRF ist das digitale Repositorium der Fachhochschule Nordwestschweiz FHNW. Es enthält Publikationen, studentische Arbeiten und Projekte.

Links

Liste der IRF Power User
Feedbackformular

www.fhnw.ch | Impressum | Datenschutz | Urheberrecht